Meet with us at

Discovery on Target (DOT)

September 30 – October 3, 2024


Registration Closes In




Discovery on Target (DOT)

Join Us in Boston for Discovery On Target 2024! It highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

Stop by Curia's Booth: 301


Schedule a meeting with Curia's experts


 
 

Meet the Experts

 

Join Curia's Thought Leadership Discussion

Using High-Content Imaging to Drive Small Molecule Protein 

Wednesday, Oct. 2 at 9:30 - 10:00AM

Clark Driscoll
Senior, Research Scientist at Curia

Clark Driscoll is a Senior Research Scientist on the Cell-Based Assay Technologies team at Curia’s integrated Drug Discovery Site in Buffalo, NY. For the past 8 years Clark has served as lead of Curia’s High-Content Imaging Core, developing microscopy assays that suit the unique needs of each client project and range from live-cell imaging to phenotypic profiling using cell painting methods. Using cutting edge automation and confocal imaging systems, Clark and his team have developed high-content imaging assays and screening campaigns to assess target protein translocation, target expression, protein degradation, target interaction, small molecule cytotoxicity, cell cycle, and much more.


At Curia, every partnership is an opportunity to transform an idea to impact.

Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.

To learn more visit us at curiaglobal.com

Sheraton Boston, 39 Dalton Street,
Boston, MA 02199

Scientific Expertise. Market-Leading Technology.
Best-in-Class Solutions.

AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.

Discover our Expert Solutions